BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28630185)

  • 1.
    Kimura G; Nakaoki T; Colley T; Rapeport G; Strong P; Ito K; Kizawa Y
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.
    Kimura G; Nakaoki T; Nishimoto Y; Suzuki Y; Rapeport G; Strong P; Ito K; Kizawa Y
    Mycoses; 2017 Nov; 60(11):728-735. PubMed ID: 28699245
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice: Pulmonary PK-PD analysis of anti-fungal PC945.
    Ito K; Kizawa Y; Kimura G; Nishimoto Y; Daly L; Knowles I; Hows M; Ayrton J; Strong P
    Eur J Pharm Sci; 2021 Aug; 163():105878. PubMed ID: 34015430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
    Colley T; Sehra G; Daly L; Kimura G; Nakaoki T; Nishimoto Y; Kizawa Y; Strong P; Rapeport G; Ito K
    Sci Rep; 2019 Jul; 9(1):9482. PubMed ID: 31263150
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
    Colley T; Sharma C; Alanio A; Kimura G; Daly L; Nakaoki T; Nishimoto Y; Bretagne S; Kizawa Y; Strong P; Rapeport G; Ito K; Meis JF; Chowdhary A
    J Antimicrob Chemother; 2019 Oct; 74(10):2950-2958. PubMed ID: 31361006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections.
    Murray A; Cass L; Ito K; Pagani N; Armstrong-James D; Dalal P; Reed A; Strong P
    J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33348852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Vazquez JA; Manavathu EK
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1129-33. PubMed ID: 26574014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
    Gebremariam T; Alkhazraji S; Gu Y; Singh S; Alqarihi A; Shaw KJ; Ibrahim AS
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
    Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
    Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
    Salas V; Pastor FJ; Calvo E; Sutton DA; Fothergill AW; Guarro J
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1404-8. PubMed ID: 23295918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2008 Sep; 62(3):539-42. PubMed ID: 18544603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
    Li SX; Song YJ; Jiang L; Zhao YJ; Guo H; Li DM; Zhu KJ; Zhang H
    Microb Drug Resist; 2017 Sep; 23(6):674-681. PubMed ID: 28080217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
    Idelevich EA; Groß U; Becker K; Bader O
    Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
    Rudramurthy SM; Colley T; Abdolrasouli A; Ashman J; Dhaliwal M; Kaur H; Armstrong-James D; Strong P; Rapeport G; Schelenz S; Ito K; Chakrabarti A
    J Antimicrob Chemother; 2019 Oct; 74(10):2943-2949. PubMed ID: 31325309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Mello E; Posteraro B; Vella A; De Carolis E; Torelli R; D'Inzeo T; Verweij PE; Sanguinetti M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.
    Lewis RE; Verweij PE
    J Infect Dis; 2017 Aug; 216(suppl_3):S466-S473. PubMed ID: 28911046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of the Orotomides against
    Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.